McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
749.76
-5.99 (-0.79%)
Oct 9, 2025, 11:28 AM EDT - Market open
McKesson Employees
McKesson had 51,000 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
51,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$7,403,824
Profits / Employee
$62,039
Market Cap
93.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 51,000 | 0 | - |
Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
Mar 31, 2020 | 80,000 | 0 | - |
Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
Mar 31, 2018 | 78,000 | 0 | - |
Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
Mar 31, 2014 | 42,800 | -700 | -1.61% |
Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
Mar 31, 2010 | 32,500 | 0 | - |
Mar 31, 2009 | 32,500 | -400 | -1.22% |
Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
Mar 31, 2005 | 25,200 | 600 | 2.44% |
Mar 31, 2004 | 24,600 | 100 | 0.41% |
Mar 31, 2003 | 24,500 | 500 | 2.08% |
Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
Mar 31, 1998 | 13,700 | 400 | 3.01% |
Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
Mar 31, 1996 | 11,300 | -900 | -7.38% |
Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MCK News
- 8 days ago - See How McKesson Shares Rise with Money Flows - FXEmpire
- 15 days ago - McKesson Corporation (MCK) Analyst/Investor Day Transcript - Seeking Alpha
- 16 days ago - McKesson lifts annual profit forecast on plans to focus on high-margin businesses - Reuters
- 16 days ago - McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day - Business Wire
- 21 days ago - Drug distributor McKesson to restructure segments to focus on high-margin businesses - Reuters
- 21 days ago - McKesson Announces New Organizational Structure - Business Wire
- 2 months ago - McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mckesson lifts annual profit forecast on robust demand for specialty drugs - Reuters